Pinnacle Wealth Planning Services, Inc. Aeglea Bio Therapeutics, Inc. Transaction History

Pinnacle Wealth Planning Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$1.87 - $4.77 $18,943 - $48,320	-10,130 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$3.5 - $8.42 $35,455 - $85,294	10,130 New	10,130 $48,000
Q1 2021 Apr 29, 2021	SELL	$6.76 - $8.57 $966 - $1,225	-143 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$7.02 - $9.83 $1,003 - $1,405	143 New	143 $1,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.